6 results match your criteria: "Yale School of Medicine. Electronic address: dennis.shung@yale.edu.[Affiliation]"
Gastroenterology
January 2025
Section of Digestive Diseases, Department of Medicine, Yale School of Medicine; Department of Biomedical Informatics and Data Science, Yale School of Medicine. Electronic address:
Gastroenterology
January 2025
Section of Digestive Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut; Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut; Clinical and Translational Research Accelerator, Department of Medicine, Yale School of Medicine, New Haven, Connecticut. Electronic address:
Gastroenterology
November 2024
Section of Digestive Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut; West Haven Veterans Affairs Medical Center, West Haven, Connecticut.
Am J Med
May 2024
Section of Digestive Diseases, Department of Medicine, Yale School of Medicine. Electronic address:
Am J Med
December 2023
Section of Digestive Diseases, Department of Medicine, Yale School of Medicine, New Haven, Conn. Electronic address:
Background: Recent guidelines do not recommend routine use of aspirin for primary cardiovascular prevention (ppASA) and suggest avoidance of ppASA in older individuals due to bleeding risk. However, ppASA is frequently taken without an appropriate indication. Estimates of the incidence of upper gastrointestinal bleeding due to ppASA in the United States are lacking.
View Article and Find Full Text PDFGastroenterology
January 2020
Yale School of Medicine, New Haven, Connecticut; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut. Electronic address:
Background & Aims: Scoring systems are suboptimal for determining risk in patients with upper gastrointestinal bleeding (UGIB); these might be improved by a machine learning model. We used machine learning to develop a model to calculate the risk of hospital-based intervention or death in patients with UGIB and compared its performance with other scoring systems.
Methods: We analyzed data collected from consecutive unselected patients with UGIB from medical centers in 4 countries (the United States, Scotland, England, and Denmark; n = 1958) from March 2014 through March 2015.